PRF Technologies (PRFX) Operating Leases (2023 - 2025)

PRF Technologies (PRFX) recorded quarterly Operating Leases of $56000.0 in Q2 2025, up 24.44% on a QoQ basis from $45000.0 in Q4 2024, and down 1.75% year-over-year from $57000.0 in Q2 2024.

PRF Technologies (PRFX) Operating Leases (2023 - 2025) Analysis & Trends

PRF Technologies has disclosed Operating Leases across 3 years of filings, most recently posting $56000.0 for Q2 2025.

  • Quarterly Operating Leases fell 1.75% year-over-year to $56000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $56000.0 (down 1.75% YoY) and the FY2024 annual result came in at $45000.0, up 50.0% from the prior year.
  • Operating Leases advanced to $56000.0 in Q2 2025, from $45000.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $57000.0 in Q1 2024 and troughed at $30000.0 in Q4 2023.
  • A 3-year average of $50000.0 and a median of $55500.0 in 2023 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2024 — Operating Leases jumped 50.0% — and 2025, when it fell 1.75%.
  • Tracing PRFX's Operating Leases over 3 years: stood at $30000.0 in 2023, then soared by 50.0% to $45000.0 in 2024, then rose by 24.44% to $56000.0 in 2025.
  • Business Quant data shows PRFX's Operating Leases at $56000.0 in Q2 2025, $45000.0 in Q4 2024, and $57000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 PRF Technologies 933,081.16 -2.46 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 56,000.00
Dec 31, 2024 45,000.00
Jun 30, 2024 57,000.00
Mar 31, 2024 57,000.00
Dec 31, 2023 30,000.00
Sep 30, 2023 55,000.00